Upendra Nagaich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Upendra Nagaich has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Neha Jain
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
17 shared publications - Shreya Kaul
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
14 shared publications Neha Gulati
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh 201301, India
12 shared publications- Neha Gulati
Department of Pharmaceutics, School of Pharmacy, Bharat Institute of Technology, Meerut, UP, India
4 shared publications Shreya Kaul
Centre for Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
4 shared publications- Amit Chaudhary
Chitkara University School of Pharmacy, Chitkara University, Baddi, Himachal Pradesh, 174103, India
3 shared publications
Latest Publications
- 12 November 2026
- Published by Springer Nature in Microchimica Acta
- Vol. 193 (12)
Biofilm-responsive nanogels: a closed-loop system for on-demand antimicrobial release for chronic wounds
- 12 November 2026
- Published by Springer Nature in Microchimica Acta
- Vol. 193 (12)
Biofilm-responsive nanogels: a closed-loop system for on-demand antimicrobial release for chronic wounds
- 1 November 2026
- Published by Bentham Science Publishers Ltd. in Recent Patents on Nanotechnology
- Vol. 20 (4) , 370-394
Nano-based Strategies for Leishmaniasis: Overcoming Drug Resistance, Toxicity, and Delivery Barriers to Transform Clinical Management and Accelerate Translation
Introduction: Leishmaniasis, caused by Leishmania protozoa, is a serious health issue in the endemic areas. Conventional therapies are common but are plagued with drug resistance, toxicity, poor drug availability, and minimal therapeutic outcomes. Recent developments in nanotechnology, along with patent-protected formulations, present new therapeutic prospects by enhancing the solubility, bio-distribution, and targeted delivery of drugs, thus eliminating most of the undesirable effects that traditional treatments have. Methods: The literature search and selection process was conducted in a structured and transparent manner, following a PRISMA-inspired approach. Literature search was conducted across major scientific databases, such as PubMed, Springer, and ScienceDirect, with key terms that included: nanoparticles in leishmaniasis, nanocarriers of leishmaniasis management, and nanoformulations of leishmaniasis. Only original in vivo studies published in the past decade were considered, and reviews, commentaries, and non-efficacy studies were excluded. Results: The primary search produced 1,432 articles, which were narrowed down to 1,150 through elimination of duplicates. A total of 32 studies were found after the screening and application of inclusion/ exclusion criteria. Together, these studies concluded that nano-based systems enhanced the drug solubility, stability, and targeted macrophage delivery, as well as reducing systemic toxicity in comparison to conventional treatment. The majority of formulations had increased parasite clearance in vivo, extended drug circulation, and a lower frequency. Discussion: Research studies demonstrated that different nanoparticle systems, such as liposomes, polymeric, lipid-based, vesicular-based, and metallic nanoparticles, exhibited controlled release, prolonged blood circulation, and mechanisms of avoiding parasite resistance mechanisms. Such encouraging results have not yet translated into practice. Regulatory uncertainties, high cost, and largescale reproducibility are major barriers. However, nano-based strategies coupled with artificial intelligence- driven design have the potential to accelerate clinical translation in endemic regions. Conclusion: Nanotechnology is a new paradigm for the management of leishmaniasis. The development of multidisciplinary collaboration and concentrated research is required to enhance clinical acceptance, cost reduction, and accessibility in endemic areas.
- 1 November 2026
- Published by Bentham Science Publishers Ltd. in Recent Patents on Nanotechnology
- Vol. 20 (4) , 370-394
Nano-based Strategies for Leishmaniasis: Overcoming Drug Resistance, Toxicity, and Delivery Barriers to Transform Clinical Management and Accelerate Translation
Introduction: Leishmaniasis, caused by Leishmania protozoa, is a serious health issue in the endemic areas. Conventional therapies are common but are plagued with drug resistance, toxicity, poor drug availability, and minimal therapeutic outcomes. Recent developments in nanotechnology, along with patent-protected formulations, present new therapeutic prospects by enhancing the solubility, bio-distribution, and targeted delivery of drugs, thus eliminating most of the undesirable effects that traditional treatments have. Methods: The literature search and selection process was conducted in a structured and transparent manner, following a PRISMA-inspired approach. Literature search was conducted across major scientific databases, such as PubMed, Springer, and ScienceDirect, with key terms that included: nanoparticles in leishmaniasis, nanocarriers of leishmaniasis management, and nanoformulations of leishmaniasis. Only original in vivo studies published in the past decade were considered, and reviews, commentaries, and non-efficacy studies were excluded. Results: The primary search produced 1,432 articles, which were narrowed down to 1,150 through elimination of duplicates. A total of 32 studies were found after the screening and application of inclusion/ exclusion criteria. Together, these studies concluded that nano-based systems enhanced the drug solubility, stability, and targeted macrophage delivery, as well as reducing systemic toxicity in comparison to conventional treatment. The majority of formulations had increased parasite clearance in vivo, extended drug circulation, and a lower frequency. Discussion: Research studies demonstrated that different nanoparticle systems, such as liposomes, polymeric, lipid-based, vesicular-based, and metallic nanoparticles, exhibited controlled release, prolonged blood circulation, and mechanisms of avoiding parasite resistance mechanisms. Such encouraging results have not yet translated into practice. Regulatory uncertainties, high cost, and largescale reproducibility are major barriers. However, nano-based strategies coupled with artificial intelligence- driven design have the potential to accelerate clinical translation in endemic regions. Conclusion: Nanotechnology is a new paradigm for the management of leishmaniasis. The development of multidisciplinary collaboration and concentrated research is required to enhance clinical acceptance, cost reduction, and accessibility in endemic areas.
- Open Access
Zirconium Dioxide Nanoparticles in Bone Tissue Engineering: Recent Advances, Biological Interactions, and Future Perspectives
Bone defects from trauma, tumor resection, infection, and degenerative disease remain a large clinical problem, and the grafting strategies used to treat them still carry familiar limitations: donor-site morbidity for autografts, variable integration and supply constraints for allografts. Synthetic substitutes have narrowed the gap but rarely combine mechanical competence with biological activity in a single material. Zirconium dioxide (ZrO2) has been used in orthopedics and dentistry for decades on the strength of its fracture toughness, which derives from the stress-induced tetragonal-to-monoclinic transformation, together with chemical stability and an established safety record. At the nanoscale, ZrO2 can provide functionalities beyond mechanical reinforcement in appropriately engineered systems. Its high surface area, tunable surface chemistry, and potential mesoporosity have been exploited in selected formulations for matrix reinforcement, surface-mediated cellular interactions, therapeutic cargo loading and release, and antibacterial applications. This review covers the physicochemical basis of ZrO2 behavior, including crystal phases, transformation toughening, surface chemistry and hydrothermal stability, and the influence of synthesis route on particle size and dispersion, and links these to protein adsorption, osteoblast response, osteogenic signaling, and immunomodulatory and antibacterial effects. Recent applications are surveyed across scaffold reinforcement, bone cements and fillers, implant surface modification, local drug delivery, and infection control. Recurring issues are examined throughout, including the reported loading ranges associated with mechanical performance and the effects of particle agglomeration, the confounding effect of porosity on reported strength, and the need to pair ZrO2’s bioinertness with bioactive phases. The review closes with cytotoxicity, long-term particle fate, scale-up and regulatory barriers, and prospects in additive manufacturing, personalized grafts, and theragnostic design.
Open AccessZirconium Dioxide Nanoparticles in Bone Tissue Engineering: Recent Advances, Biological Interactions, and Future Perspectives
Bone defects from trauma, tumor resection, infection, and degenerative disease remain a large clinical problem, and the grafting strategies used to treat them still carry familiar limitations: donor-site morbidity for autografts, variable integration and supply constraints for allografts. Synthetic substitutes have narrowed the gap but rarely combine mechanical competence with biological activity in a single material. Zirconium dioxide (ZrO2) has been used in orthopedics and dentistry for decades on the strength of its fracture toughness, which derives from the stress-induced tetragonal-to-monoclinic transformation, together with chemical stability and an established safety record. At the nanoscale, ZrO2 can provide functionalities beyond mechanical reinforcement in appropriately engineered systems. Its high surface area, tunable surface chemistry, and potential mesoporosity have been exploited in selected formulations for matrix reinforcement, surface-mediated cellular interactions, therapeutic cargo loading and release, and antibacterial applications. This review covers the physicochemical basis of ZrO2 behavior, including crystal phases, transformation toughening, surface chemistry and hydrothermal stability, and the influence of synthesis route on particle size and dispersion, and links these to protein adsorption, osteoblast response, osteogenic signaling, and immunomodulatory and antibacterial effects. Recent applications are surveyed across scaffold reinforcement, bone cements and fillers, implant surface modification, local drug delivery, and infection control. Recurring issues are examined throughout, including the reported loading ranges associated with mechanical performance and the effects of particle agglomeration, the confounding effect of porosity on reported strength, and the need to pair ZrO2’s bioinertness with bioactive phases. The review closes with cytotoxicity, long-term particle fate, scale-up and regulatory barriers, and prospects in additive manufacturing, personalized grafts, and theragnostic design.
- Open Access
- 17 July 2026
- Published by MDPI AG in Marine Drugs
- Vol. 24 (7) , 249
Quaternary Ammonium-Functionalized Chitosan as a Next-Generation Antifungal Platform: Chemistry, Mechanisms, and Therapeutic Applications
Fungal infection remains a significant therapeutic concern owing to the scarcity of drugs, resistance development, and high levels of toxicity of many conventional antifungals. In this regard, chitosan is one such natural polymer whose biocompatibility, biodegradability, and antimicrobial nature have made it the focus of scientific interest. However, the main problem lies in the polymer’s limited aqueous solubility under physiological conditions and its poor efficacy against fungi. Thus, quaternary ammonium functionalization represents a convenient approach to solving the problem by introducing permanent positive charges into the molecular structure of chitosan, thereby improving water solubility, enabling membrane interactions, and conferring broad-spectrum antifungal activity. Such derivatives can exhibit strong interactions with the negatively charged surface of fungal cells, compromising membrane integrity and inhibiting biofilm formation. Apart from their antifungal activity, such compounds are also promising in local delivery systems, which include coatings, nanoparticles, hydrogels, and wound dressings. Considering their unique chemistry, such compounds appear quite promising for the development of novel antifungal biomaterials that can be adapted to different clinical and pharmaceutical needs. Overall, quaternary ammonium-modified chitosan could be considered a promising platform for the development of next-generation antifungal agents. This review offers a comprehensive discussion regarding the synthesis, mode of action, formulation advancements, safety profile, potential applications, and future directions of quaternary ammonium-functionalized chitosan derivatives as an antifungal agent, with an emphasis on artificial intelligence contributions to this area of research.
- 17 July 2026
- Published by MDPI AG in Marine Drugs
- Vol. 24 (7) , 249
Open AccessQuaternary Ammonium-Functionalized Chitosan as a Next-Generation Antifungal Platform: Chemistry, Mechanisms, and Therapeutic Applications
Fungal infection remains a significant therapeutic concern owing to the scarcity of drugs, resistance development, and high levels of toxicity of many conventional antifungals. In this regard, chitosan is one such natural polymer whose biocompatibility, biodegradability, and antimicrobial nature have made it the focus of scientific interest. However, the main problem lies in the polymer’s limited aqueous solubility under physiological conditions and its poor efficacy against fungi. Thus, quaternary ammonium functionalization represents a convenient approach to solving the problem by introducing permanent positive charges into the molecular structure of chitosan, thereby improving water solubility, enabling membrane interactions, and conferring broad-spectrum antifungal activity. Such derivatives can exhibit strong interactions with the negatively charged surface of fungal cells, compromising membrane integrity and inhibiting biofilm formation. Apart from their antifungal activity, such compounds are also promising in local delivery systems, which include coatings, nanoparticles, hydrogels, and wound dressings. Considering their unique chemistry, such compounds appear quite promising for the development of novel antifungal biomaterials that can be adapted to different clinical and pharmaceutical needs. Overall, quaternary ammonium-modified chitosan could be considered a promising platform for the development of next-generation antifungal agents. This review offers a comprehensive discussion regarding the synthesis, mode of action, formulation advancements, safety profile, potential applications, and future directions of quaternary ammonium-functionalized chitosan derivatives as an antifungal agent, with an emphasis on artificial intelligence contributions to this area of research.
- 10 June 2026
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 23 (8) , 1-25
Bioconjugates for breast cancer theranostics: improving target selectivity and treatment efficacy
1. Breast cancer is one of the most frequently diagnosed cancers worldwide, and it is a markedly heterogeneous disorder. Heterogeneity in breast cancer is seen at various levels, such as interpatie...
- 10 June 2026
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 23 (8) , 1-25
Bioconjugates for breast cancer theranostics: improving target selectivity and treatment efficacy
1. Breast cancer is one of the most frequently diagnosed cancers worldwide, and it is a markedly heterogeneous disorder. Heterogeneity in breast cancer is seen at various levels, such as interpatie...
- 18 December 2025
- Published by Springer Nature in BioNanoScience
- Vol. 16 (1) , 57
Azithromycin-based Albumin Nanoparticles Loaded Oral Fast-dissolving Films as Superheroes in the Fight against Strep Throat
- 18 December 2025
- Published by Springer Nature in BioNanoScience
- Vol. 16 (1) , 57
Azithromycin-based Albumin Nanoparticles Loaded Oral Fast-dissolving Films as Superheroes in the Fight against Strep Throat
- Open Access
- 31 August 2025
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 41 (4) , 1356-1361
Comprehensive Evaluation of Betamethasone Valerate Loaded Ethosomal Gel: Physiochemical and Ex-Vivo Permeation Studies
Psoriasis is a chronic inflammatory skin illness characterized by excessive growth of skin cells, causing substantial discomfort and a lower quality of life for those affected. The studies aim to develop and test an ethosomal gel formulation for the effective treatment of psoriasis by combining ethosomes improved skin permeability with the controlled release features of a hydrogel matrix. Phospholipids and ethanol were used to generate the ethosomal gel, which encapsulates proven anti-psoriatic medications. These ethosomes were incorporated into hydrogels formulated with varying concentrations of Carbopol 940 (0.5%, 1.0%, and 1.5%). The ethogels were assessed for their physicochemical characteristics, including appearance, pH, viscosity, spreadability, and drug content uniformity. Among the formulations, eG2 (1.0% Carbopol) demonstrated optimal spreadability, homogeneity, and drug content distribution. Ex vivo permeation studies using goat ear skin indicated that EG2 achieved the highest steady-state flux, permeability coefficient was 2.06cm/h, and cumulative drug permeation was 36.18mg/cm2 over 24 hours. The results suggest that ethosomes-loaded gels significantly enhance the permeability and stability of topical betamethasone valerate, providing a promising formulation strategy for psoriasis treatment. Further clinical evaluations are warranted to substantiate these findings and explore broader dermatological applications.
- 31 August 2025
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 41 (4) , 1356-1361
Open AccessComprehensive Evaluation of Betamethasone Valerate Loaded Ethosomal Gel: Physiochemical and Ex-Vivo Permeation Studies
Psoriasis is a chronic inflammatory skin illness characterized by excessive growth of skin cells, causing substantial discomfort and a lower quality of life for those affected. The studies aim to develop and test an ethosomal gel formulation for the effective treatment of psoriasis by combining ethosomes improved skin permeability with the controlled release features of a hydrogel matrix. Phospholipids and ethanol were used to generate the ethosomal gel, which encapsulates proven anti-psoriatic medications. These ethosomes were incorporated into hydrogels formulated with varying concentrations of Carbopol 940 (0.5%, 1.0%, and 1.5%). The ethogels were assessed for their physicochemical characteristics, including appearance, pH, viscosity, spreadability, and drug content uniformity. Among the formulations, eG2 (1.0% Carbopol) demonstrated optimal spreadability, homogeneity, and drug content distribution. Ex vivo permeation studies using goat ear skin indicated that EG2 achieved the highest steady-state flux, permeability coefficient was 2.06cm/h, and cumulative drug permeation was 36.18mg/cm2 over 24 hours. The results suggest that ethosomes-loaded gels significantly enhance the permeability and stability of topical betamethasone valerate, providing a promising formulation strategy for psoriasis treatment. Further clinical evaluations are warranted to substantiate these findings and explore broader dermatological applications.
- Open Access
- 31 August 2025
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 41 (4) , 1188-1193
Exploration of Skin Permeability Possibility of Cubogels for Keratosis-like Skin Conditions
Actinic keratosis (AK) is a chronic skin condition caused primarily by prolonged sun exposure, leading to the development of uneven, scaly patches on sun-exposed areas like the face, chest, and neck. Traditional treatments often encounter challenges such as poor skin permeability and formulation stability. This study investigates the potential of cubosomal hydrogels for enhancing the treatment of AK, focusing on their permeability, and effectiveness. Cubosomes, a type of liquid crystalline nanoparticle, are known for their controlled release and improved skin penetration capabilities. We formulated tretinoin-loaded cubosomes and incorporated them into carbopol-based hydrogels, referred to as cubogels, to address issues related to stability and ease of application. The formulation of tretinoin-loaded cubosomes was optimized, resulting in particles with a size of 69.5 nm, a polydispersity index of 0.312, and an entrapment efficiency of 82.13%. These cubosomes were then dispersed in hydrogels made with varying concentrations of Carbopol 940 (0.5%, 1.0%, and 1.5%). The cubogels were evaluated for physical properties, including appearance, pH, viscosity, spreadability, and drug content uniformity. The hydrogels exhibited good homogeneity and appropriate pH levels, with CG2 (1.0% Carbopol) showing the best spreadability and drug content uniformity. Ex-vivo studies using goat ear pinna demonstrated that CG2 provided the highest steady-state flux and permeability coefficient, indicating superior skin penetration. The cumulative drug permeation over 24 hours was also higher for CG2 compared to the other formulations. In conclusion, the incorporation of cubosomes into hydrogels significantly enhances the stability and skin permeability of tretinoin, offering a promising approach for the treatment of actinic keratosis. Future studies should focus on clinical evaluation to confirm these findings and further optimize the formulation for broader therapeutic applications.
- 31 August 2025
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 41 (4) , 1188-1193
Open AccessExploration of Skin Permeability Possibility of Cubogels for Keratosis-like Skin Conditions
Actinic keratosis (AK) is a chronic skin condition caused primarily by prolonged sun exposure, leading to the development of uneven, scaly patches on sun-exposed areas like the face, chest, and neck. Traditional treatments often encounter challenges such as poor skin permeability and formulation stability. This study investigates the potential of cubosomal hydrogels for enhancing the treatment of AK, focusing on their permeability, and effectiveness. Cubosomes, a type of liquid crystalline nanoparticle, are known for their controlled release and improved skin penetration capabilities. We formulated tretinoin-loaded cubosomes and incorporated them into carbopol-based hydrogels, referred to as cubogels, to address issues related to stability and ease of application. The formulation of tretinoin-loaded cubosomes was optimized, resulting in particles with a size of 69.5 nm, a polydispersity index of 0.312, and an entrapment efficiency of 82.13%. These cubosomes were then dispersed in hydrogels made with varying concentrations of Carbopol 940 (0.5%, 1.0%, and 1.5%). The cubogels were evaluated for physical properties, including appearance, pH, viscosity, spreadability, and drug content uniformity. The hydrogels exhibited good homogeneity and appropriate pH levels, with CG2 (1.0% Carbopol) showing the best spreadability and drug content uniformity. Ex-vivo studies using goat ear pinna demonstrated that CG2 provided the highest steady-state flux and permeability coefficient, indicating superior skin penetration. The cumulative drug permeation over 24 hours was also higher for CG2 compared to the other formulations. In conclusion, the incorporation of cubosomes into hydrogels significantly enhances the stability and skin permeability of tretinoin, offering a promising approach for the treatment of actinic keratosis. Future studies should focus on clinical evaluation to confirm these findings and further optimize the formulation for broader therapeutic applications.
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 22 (2) , 195-214
Intelligent Drug Delivery: Pioneering Stimuli-Responsive Systems to Revolutionize Disease Management- An In-depth Exploration
In recent years, there has been an escalating interest in stimuli-responsive drug delivery systems (SRDDS) due to their ability to revolutionize the delivery of therapeutics. SRDDSs offer a multitude of benefits in comparison to conventional drug delivery systems (DDS), including spatiotemporal control of drug release, targeted delivery, and improved therapeutic efficacy. The development of various classes of stimuli-responsive DDS, such as pH-responsive, temperature-responsive, photo-responsive, redox responsive systems, has been propelled by advances in materials science, nanotechnology, and biotechnology. These systems exploit specific environmental or physiological cues to trigger drug release in a precisely controlled manner, making them highly promising for the treatment of various diseases. In this review article, an in-depth exploration of the principles, mechanisms, and applications of SRDDS in the context of diverse pathologies such as cancer, arthritis, Alzheimer’s disease, atherosclerosis and tissue engineering has been provided. Furthermore, this article delves into the discussion of recent patents, market overview and the progress of research in clinical trials. Overall, this article underscores the transformative potential of SRDDS in enabling personalized, precise, and effective drug delivery for the treatment of the above-mentioned diseases.
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 22 (2) , 195-214
Intelligent Drug Delivery: Pioneering Stimuli-Responsive Systems to Revolutionize Disease Management- An In-depth Exploration
In recent years, there has been an escalating interest in stimuli-responsive drug delivery systems (SRDDS) due to their ability to revolutionize the delivery of therapeutics. SRDDSs offer a multitude of benefits in comparison to conventional drug delivery systems (DDS), including spatiotemporal control of drug release, targeted delivery, and improved therapeutic efficacy. The development of various classes of stimuli-responsive DDS, such as pH-responsive, temperature-responsive, photo-responsive, redox responsive systems, has been propelled by advances in materials science, nanotechnology, and biotechnology. These systems exploit specific environmental or physiological cues to trigger drug release in a precisely controlled manner, making them highly promising for the treatment of various diseases. In this review article, an in-depth exploration of the principles, mechanisms, and applications of SRDDS in the context of diverse pathologies such as cancer, arthritis, Alzheimer’s disease, atherosclerosis and tissue engineering has been provided. Furthermore, this article delves into the discussion of recent patents, market overview and the progress of research in clinical trials. Overall, this article underscores the transformative potential of SRDDS in enabling personalized, precise, and effective drug delivery for the treatment of the above-mentioned diseases.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Recent Patents on Nanotechnology
- Vol. 18 (3) , 305-320
Nanoneuroscience: Cutting-edge Approach for Disease Management
Neurological disorders (ND) have affected a major part of our society and have been a challenge for medical and biosciences for decades. However, many of these disorders haven't responded well to currently established treatment approaches. The fact that many active pharmaceutical ingredients can't get to their specified action site inside the body is one of the main reasons for this failure. Extracellular and intracellular central nervous system (CNS) barriers prevent the transfer of drugs from the blood circulation to the intended location of the action. Utilizing nanosized drug delivery technologies is one possible way to overcome these obstacles. These nano-drug carriers outperform conventional dosage forms in many areas, including good drug encapsulation capacity, targeted drug delivery, less toxicity, and enhanced therapeutic impact. As a result, nano-neuroscience is growing to be an intriguing area of research and a bright alternative approach for delivering medicines to their intended action site for treating different neurological and psychiatric problems. In this review, we have included a short overview of the pathophysiology of neurological diseases, a detailed discussion about the significance of nanocarriers in NDs, and a focus on its recent advances. Finally, we highlighted the patented technologies and market trends, including the predictive analysis for the years 2021-2028.
- 1 September 2024
- Published by Bentham Science Publishers Ltd. in Recent Patents on Nanotechnology
- Vol. 18 (3) , 305-320
Nanoneuroscience: Cutting-edge Approach for Disease Management
Neurological disorders (ND) have affected a major part of our society and have been a challenge for medical and biosciences for decades. However, many of these disorders haven't responded well to currently established treatment approaches. The fact that many active pharmaceutical ingredients can't get to their specified action site inside the body is one of the main reasons for this failure. Extracellular and intracellular central nervous system (CNS) barriers prevent the transfer of drugs from the blood circulation to the intended location of the action. Utilizing nanosized drug delivery technologies is one possible way to overcome these obstacles. These nano-drug carriers outperform conventional dosage forms in many areas, including good drug encapsulation capacity, targeted drug delivery, less toxicity, and enhanced therapeutic impact. As a result, nano-neuroscience is growing to be an intriguing area of research and a bright alternative approach for delivering medicines to their intended action site for treating different neurological and psychiatric problems. In this review, we have included a short overview of the pathophysiology of neurological diseases, a detailed discussion about the significance of nanocarriers in NDs, and a focus on its recent advances. Finally, we highlighted the patented technologies and market trends, including the predictive analysis for the years 2021-2028.